0001772028-20-000002.txt : 20200710 0001772028-20-000002.hdr.sgml : 20200710 20200709213202 ACCESSION NUMBER: 0001772028-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200710 DATE AS OF CHANGE: 20200709 EFFECTIVENESS DATE: 20200710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scopus BioPharma Inc. CENTRAL INDEX KEY: 0001772028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821248020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-370654 FILM NUMBER: 201021610 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: (212) 479-2513 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: Scopus Biopharma Inc. DATE OF NAME CHANGE: 20190327 D/A 1 primary_doc.xml X0708 D/A LIVE 0001772028 Scopus BioPharma Inc. 5 Penn Plaza 23rd Floor NEW YORK NY NEW YORK 10005 2124792513 DELAWARE Project18 Inc. Scopus Biopharma Inc. Corporation true 2017 Joshua R. Lamstein 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Executive Officer Director Co-Chairman and Director Paul J. Hopper 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Executive Officer Director Co-Chairman and Director Robert J. Gibson 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Executive Officer Director Vice Chairman, Secretary, Treasurer and Director Ira Scott Greenspan 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Director Ashish P. Sanghrajka 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Executive Officer Director President and Director Pharmaceuticals No Revenues 06b true 0001772028-20-000001 2019-12-23 false true true false 0 HCFP/Capital Markets LLC 149111 None None 747 Third Avenue Floor 2 New York NY NEW YORK 10017 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KY KENTUCKY MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO TX TEXAS UT UTAH VA VIRGINIA false 2252000 1911600 340400 false 24 191160 true 0 The placement agent is entitled to a placement fee equal to 8% of the gross proceeds of this offering. In addition, a non-accountable expense allowance of 2% of funds raised will be paid to placement agent. 46175 true Executive officer compensation. false Scopus BioPharma Inc. Robert J. Gibson Robert J. Gibson Vice Chairman 2020-07-09